Skip to main content
. 2017 Oct 24;26(3):933–945. doi: 10.1007/s00520-017-3914-2

Fig. 1.

Fig. 1

Time courses of a the Quality of Life Questionnaire for Cancer Patients Treated with Anticancer Drugs-Breast (QOL-ACD-B) score (total score of items 1 to 18) and b the Functional Assessment of Cancer Therapy-Endocrine Symptoms (FACT-ES) subscale score (except for BRM1) from week 0 to 240 (full analysis set). The FACT-ES subscale score is inverted according to the QOL-ACD-B score. Data indicate the mean + SD. SD, standard deviation